Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9445)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Morishita A, Gong J, Masaki T. Targeting receptor tyrosine kinases in gastric cancer. World J Gastroenterol 2014; 20(16): 4536-4545 [PMID: 24782606 DOI: 10.3748/wjg.v20.i16.4536] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i16/4536.htm |
| Number | Citing Articles |
| 1 |
Min Rao, Yonggang Zhu, Xiaoxia Cong, Qianxun Li. Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo. Oncology Reports 2017; 37(6): 3361 doi: 10.3892/or.2017.5636
|
| 2 |
Manuel H. Schäfer, Philipp Lingohr, Anke Sträßer, Nils C. Lehnen, Martin Braun, Sven Perner, Tobias Höller, Glen Kristiansen, Jörg C. Kalff, Ines Gütgemann. Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma. Human Pathology 2015; 46(10): 1488 doi: 10.1016/j.humpath.2015.06.007
|
| 3 |
Yalei Lv, Lina Song, Liang Chang, Xiaolin Zhang, Yan Liu, Wei Liu. Effect of bevacizumab combined with chemotherapy at different sequences in the gastric-cancer-bearing nude mice. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 1): S190 doi: 10.4103/0973-1482.171364
|
| 4 |
Yudai Hojo, Shingo Kishi, Shiori Mori, Rina Fujiwara-Tani, Takamitsu Sasaki, Kiyomu Fujii, Yukiko Nishiguchi, Chie Nakashima, Yi Luo, Hisashi Shinohara, Hiroki Kuniyasu. Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8. International Journal of Molecular Sciences 2022; 23(7): 4002 doi: 10.3390/ijms23074002
|
| 5 |
Mauricio P. Pinto, Gareth I. Owen, Ignacio Retamal, Marcelo Garrido. Angiogenesis inhibitors in early development for gastric cancer. Expert Opinion on Investigational Drugs 2017; 26(9): 1007 doi: 10.1080/13543784.2017.1361926
|
| 6 |
Yuka Hirashita, Yoshiyuki Tsukamoto, Kazuyoshi Yanagihara, Shoichi Fumoto, Naoki Hijiya, Chisato Nakada, Tomohisa Uchida, Keiko Matsuura, Masaaki Kodama, Tadayoshi Okimoto, Tsutomu Daa, Masataka Seike, Hidekatsu Iha, Kuniaki Shirao, Kazunari Murakami, Masatsugu Moriyama. Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells. Cancer Science 2016; 107(12): 1919 doi: 10.1111/cas.13094
|
| 7 |
Ting Yin, Peng Huang, Guo Gao, Joseph G. Shapter, Yulan Shen, Rongjin Sun, Caixia Yue, Chunlei Zhang, Yanlei Liu, Sui Zhou, Daxiang Cui. Superparamagnetic Fe3O4-PEG2K-FA@Ce6 Nanoprobes for in Vivo Dual-mode Imaging and Targeted Photodynamic Therapy. Scientific Reports 2016; 6(1) doi: 10.1038/srep36187
|
| 8 |
Marie‐Luise Metzger, Hans‐Michael Behrens, Christine Böger, Jochen Haag, Sandra Krüger, Christoph Röcken. MET in gastric cancer – discarding a 10% cutoff rule. Histopathology 2016; 68(2): 241 doi: 10.1111/his.12745
|
| 9 |
X Hu, S-H Dong, J Chen, X Z Zhou, R Chen, S Nair, K P Lu, L-F Chen. Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4. Oncogene 2017; 36(36): 5177 doi: 10.1038/onc.2017.137
|
| 10 |
Muzammil Muhammad Khan, Deepika Sarvepalli, Mamoon Ur Rashid, Hammad Zafar, Muhammad Shayan Khan, Effa Zahid, Akash Khetpal, Bayarmaa Mandzhieva, Rima Shobar, Anum Jalil, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 189 doi: 10.1007/978-3-030-48405-7_9
|
| 11 |
Derek Essegian, Rimpi Khurana, Vasileios Stathias, Stephan C. Schürer. The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer. Cell Reports Medicine 2020; 1(7): 100128 doi: 10.1016/j.xcrm.2020.100128
|
| 12 |
Jing Guo, Xuxian Zhong, Qinglin Tan, Shengnan Yang, Jiaqi Liao, Jinke Zhuge, Ziyang Hong, Qiong Deng, Qiang Zuo. miR-301a-3p induced by endoplasmic reticulum stress mediates the occurrence and transmission of trastuzumab resistance in HER2-positive gastric cancer. Cell Death & Disease 2021; 12(7) doi: 10.1038/s41419-021-03991-3
|
| 13 |
Luchun Li, Yan Li, Lulu Wang, Zhijuan Wu, Huiwen Ma, Jianghe Shao, Dairong Li, Huiqing Yu, Weiqi Nian, Donglin Wang. Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells. Oncology Letters 2017; 14(4): 3989 doi: 10.3892/ol.2017.6683
|
| 14 |
Charu Sonkar, Tarun Verma, Debi Chatterji, Ajay Kumar Jain, Hem Chandra Jha. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07377-0
|
| 15 |
KAI LIU, XILIN SONG, MEIRONG ZHU, HENG MA. Overexpression of FGFR2 contributes to inherent resistance to MET inhibitors in MET-amplified patient-derived gastric cancer xenografts. Oncology Letters 2015; 10(4): 2003 doi: 10.3892/ol.2015.3601
|
| 16 |
Kuldeep Sharma, P. S. Suresh, Ramesh Mullangi, N. R. Srinivas. Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors – review of assay methodologies and perspectives. Biomedical Chromatography 2015; 29(6): 803 doi: 10.1002/bmc.3370
|
| 17 |
Henrique Duarte, Daniela Freitas, Catarina Gomes, Joana Gomes, Ana Magalhães, Celso Reis. Mucin-Type O-Glycosylation in Gastric Carcinogenesis. Biomolecules 2016; 6(3): 33 doi: 10.3390/biom6030033
|
| 18 |
Shoumin Zhu, Shayan Khalafi, Zheng Chen, Julio Poveda, Dunfa Peng, Heng Lu, Mohammed Soutto, Jianwen Que, Monica Garcia-Buitrago, Alexander Zaika, Wael El-Rifai. Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib. Cancer Letters 2020; 491: 87 doi: 10.1016/j.canlet.2020.07.014
|
| 19 |
Esmeralda Celia Marginean. Gastric Cancer: Applicability and Feasibility of Molecular and Histological Classification in Clinical Practice. Journal of Medical and Radiation Oncology 2021; 1(2): 8 doi: 10.53011/JMRO.2021.02.02
|
| 20 |
Yuhui Zhang, Qian Zhang, Amin Zhang, Shaojun Pan, Jin Cheng, Xiao Zhi, Xianting Ding, Lixin Hong, Mei Zi, Daxiang Cui, Jinghua He. Multifunctional co-loaded magnetic nanocapsules for enhancing targeted MR imaging and in vivo photodynamic therapy. Nanomedicine: Nanotechnology, Biology and Medicine 2019; 21: 102047 doi: 10.1016/j.nano.2019.102047
|
| 21 |
Yoshimi Yamana, Shintaro Fujihara, Hideki Kobara, Kyoko Oura, Eri Samukawa, Taiga Chiyo, Megumi Okamura, Hiroki Yamana, Tomoko Tadokoro, Koji Fujita, Asahiro Morishita, Hisakazu Iwama, Tsutomu Masaki. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells. Journal of Cancer Research and Therapeutics 2022; 18(Suppl 2): S305 doi: 10.4103/jcrt.JCRT_104_20
|
| 22 |
Marwa Matboli, Sarah El-Nakeep, Nourhan Hossam, Alaa Habieb, Ahmed E M Azazy, Ali E Ebrahim, Ziad Nagy, Omar Abdel-Rahman. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature. World Journal of Gastroenterology 2016; 22(26): 5896-5908 doi: 10.3748/wjg.v22.i26.5896
|
| 23 |
Hai Qian, Kwaku Appiah-Kubi, Ying Wang, Min Wu, Yan Tao, Yan Wu, Yongchang Chen. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2018; 127: 15 doi: 10.1016/j.critrevonc.2018.05.004
|
| 24 |
Yang Liu, Yu Zhou, Xun Gong, Changjie Zhang. MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor. Experimental and Therapeutic Medicine 2017; 14(1): 173 doi: 10.3892/etm.2017.4477
|
| 25 |
Md. Moshfekus Saleh-e-In, Ayan Roy, Muhammad Abdullah Al-Mansur, Choudhury Mahmood Hasan, Md. Matiur Rahim, Nasim Sultana, Shamim Ahmed, Md. Rabiul Islam, Johannes van Staden. Isolation and in silico prediction of potential drug-like compounds from Anethum sowa L. root extracts targeted towards cancer therapy. Computational Biology and Chemistry 2019; 78: 242 doi: 10.1016/j.compbiolchem.2018.11.025
|
| 26 |
Deepika Sarvepalli, Mamoon Ur Rashid, Hammad Zafar, Sundas Jehanzeb, Effa Zahid, Sarfraz Ahmad. Overcoming Drug Resistance in Gynecologic Cancers. 2021; : 283 doi: 10.1016/B978-0-12-824299-5.00014-9
|
| 27 |
Ewa Marcinkowska, Elżbieta Gocek. Resistance to Tyrosine Kinase Inhibitors. Resistance to Targeted Anti-Cancer Therapeutics 2016; : 1 doi: 10.1007/978-3-319-46091-8_1
|
| 28 |
Felice Pasini, Anna Paola Fraccon, Yasmina Modena. Adenocarcinoma of the Esophagogastric Junction. 2017; : 217 doi: 10.1007/978-3-319-28776-8_22
|
| 29 |
Arash Poursheikhani, Zahra Bahmanpour, Ehsan Razmara, Ladan Mashouri, Mohammad Taheri, Dorsa Morshedi Rad, Hassan Yousefi, Amirreza Bitaraf, Sadegh Babashah. Non-coding RNAs underlying chemoresistance in gastric cancer. Cellular Oncology 2020; 43(6): 961 doi: 10.1007/s13402-020-00528-2
|
| 30 |
Sogand Vahidi, Ali Akbar Samadani. TERRA Gene Expression in Gastric Cancer: Role of hTERT. Journal of Gastrointestinal Cancer 2021; 52(2): 431 doi: 10.1007/s12029-020-00565-y
|
| 31 |
Jonathan Cools-Lartigue, Laura Baker, Lorenzo E. Ferri. Gastric Cancer. 2015; : 35 doi: 10.1007/978-3-319-15826-6_3
|
| 32 |
Ryoichi Okura, Shintaro Fujihara, Hisakazu Iwama, Asahiro Morishita, Taiga Chiyo, Miwako Watanabe, Kayo Hirose, Kiyoyuki Kobayashi, Takayuki Fujimori, Kiyohito Kato, Hideki Kamada, Hideki Kobara, Hirohito Mori, Toshiro Niki, Mitsuomi Hirashima, Keiichi Okano, Yasuyuki Suzuki, Tsutomu Masaki. MicroRNA profiles during galectin‑9‑induced apoptosis of pancreatic cancer cells. Oncology Letters 2017; doi: 10.3892/ol.2017.7316
|
| 33 |
Cristina Díaz del Arco, María Jesús Fernández Aceñero, Luis Ortega Medina. Molecular Classifications in Gastric Cancer: A Call for Interdisciplinary Collaboration. International Journal of Molecular Sciences 2024; 25(5): 2649 doi: 10.3390/ijms25052649
|
| 34 |
Xuefen Lei, Feng Wang, Yang Ke, Dong Wei, Hou Gu, Zhixian Zhang, Lifeng Jiang, Li Lv, Jie Lin, Lin Wang. The role of antiangiogenic agents in the treatment of gastric cancer. Medicine 2017; 96(10): e6301 doi: 10.1097/MD.0000000000006301
|
| 35 |
Giuseppe Tridente. Adverse Events and Oncotargeted Kinase Inhibitors. 2017; : 199 doi: 10.1016/B978-0-12-809400-6.00009-3
|
| 36 |
Ying Wang, Kwaku Appiah‐Kubi, Ting Lan, Min Wu, Ji Pang, Hai Qian, Yan Tao, Lu Jiang, Yan Wu, Yongchang Chen. PKG II inhibits PDGF‐BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells. Cell Biology International 2018; 42(10): 1358 doi: 10.1002/cbin.11020
|
| 37 |
Magdalena Skórzewska, Katarzyna Gęca, Wojciech P. Polkowski. A Clinical Viewpoint on the Use of Targeted Therapy in Advanced Gastric Cancer. Cancers 2023; 15(22): 5490 doi: 10.3390/cancers15225490
|
| 38 |
Neelam Khetpal, Saeed Ali, Ranjeet Kumar, Mamoon Ur Rashid, Sarfraz Ahmad. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 29 doi: 10.1007/978-981-13-1486-5_3
|
| 39 |
Nikita M. Volkov. New targets in gastric cancer. memo - Magazine of European Medical Oncology 2015; 8(2): 92 doi: 10.1007/s12254-015-0205-9
|
| 40 |
Moon Kyung Joo, Jong-Jae Park, Hoon Jai Chun. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management. World Journal of Gastroenterology 2016; 22(19): 4638-4650 doi: 10.3748/wjg.v22.i19.4638
|
| 41 |
Asad ur Rahman, Deepika Sarvepalli, Mamoon Ur Rashid, Saeed Ali, Awais Naeem, Asif Imran, Effa Zahid, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 169 doi: 10.1007/978-3-030-48405-7_8
|
| 42 |
Gianluca Tomasello, Michele Ghidini, Wanda Liguigli, Margherita Ratti, Laura Toppo, Rodolfo Passalacqua. Targeted therapies in gastric cancer treatment: where we are and where we are going. Investigational New Drugs 2016; 34(3): 378 doi: 10.1007/s10637-016-0330-2
|
| 43 |
JITSUKO TAKANO, ASAHIRO MORISHITA, SHINTARO FUJIHARA, HISAKAZU IWAMA, FUYUKO KOKADO, KEIKO FUJIKAWA, KOJI FUJITA, TAIGA CHIYO, TOMOKO TADOKORO, TEPPEI SAKAMOTO, TAKAKO NOMURA, JOJI TANI, HISAAKI MIYOSHI, HIROHITO YONEYAMA, HIDEKI KOBARA, HIROHITO MORI, TOSHIHIRO NIKI, MITSUOMI HIRASHIMA, TSUTOMU MASAKI. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro. Oncology Reports 2016; 35(2): 851 doi: 10.3892/or.2015.4452
|
| 44 |
Petra Minarikova, Lucie Benesova, Tereza Halkova, Barbora Belsanova, Inna Tuckova, Frantisek Belina, Ladislav Dusek, Miroslav Zavoral, Marek Minarik. Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/9408190
|